Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2025)
Quarterly results put Prepaid Assets at $63745.0 for Q4 2025, down 19.18% from a year ago — trailing twelve months through Dec 2025 was $63745.0 (down 19.18% YoY), and the annual figure for FY2025 was $63745.0, down 19.18%.
Monopar Therapeutics has reported Prepaid Assets over the past 10 years, most recently at $63745.0 for Q4 2025.
- Prepaid Assets reached $63745.0 in Q4 2025 per MNPR's latest filing, down from $414825.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $523556.0 in Q1 2025 and bottomed at $45982.0 in Q4 2022.
- Median Prepaid Assets over the past 5 years was $106809.5 (2021), compared with a mean of $159167.5.
- The largest annual shift saw Prepaid Assets tumbled 78.88% in 2022 before it soared 736.85% in 2025.
- Over 5 years, Prepaid Assets stood at $217745.0 in 2021, then crashed by 78.88% to $45982.0 in 2022, then surged by 44.48% to $66433.0 in 2023, then grew by 18.72% to $78869.0 in 2024, then dropped by 19.18% to $63745.0 in 2025.
- Business Quant data shows Prepaid Assets for MNPR at $63745.0 in Q4 2025, $414825.0 in Q3 2025, and $497294.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,745.00 |
| Sep 30, 2025 | 414,825.00 |
| Jun 30, 2025 | 497,294.00 |
| Mar 31, 2025 | 523,556.00 |
| Dec 31, 2024 | 78,869.00 |
| Sep 30, 2024 | 49,570.00 |
| Jun 30, 2024 | 61,017.00 |
| Mar 31, 2024 | 118,987.00 |
| Dec 31, 2023 | 66,433.00 |
| Sep 30, 2023 | 73,193.00 |
| Jun 30, 2023 | 109,868.00 |
| Mar 31, 2023 | 106,819.00 |
| Dec 31, 2022 | 45,982.00 |
| Sep 30, 2022 | 55,700.00 |
| Jun 30, 2022 | 189,179.00 |
| Mar 31, 2022 | 193,635.00 |
| Dec 31, 2021 | 217,745.00 |
| Sep 30, 2021 | 106,800.00 |
| Jun 30, 2021 | 95,564.00 |
| Mar 31, 2021 | 114,569.00 |
| Dec 31, 2020 | 62,690.00 |
| Sep 30, 2020 | 104,550.00 |
| Jun 30, 2020 | 183,416.00 |
| Mar 31, 2020 | 124,194.00 |
| Dec 31, 2019 | 15,711.00 |
| Sep 30, 2019 | 84,878.00 |
| Jun 30, 2019 | 94,149.00 |
| Mar 31, 2019 | 101,627.00 |
| Dec 31, 2018 | 14,516.00 |
| Sep 30, 2018 | 269,512.00 |
| Jun 30, 2018 | 228,052.00 |
| Mar 31, 2018 | 175,100.00 |
| Dec 31, 2017 | 149,342.00 |
| Dec 31, 2016 | 22,562.00 |